QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
NASDAQ:SEEL

Seelos Therapeutics (SEEL) SEC Filings & 10K Form

$0.20
0.00 (0.00%)
(As of 10/3/2023 ET)
Compare
Today's Range
$0.19
▼
$0.20
50-Day Range
$0.16
▼
$1.58
52-Week Range
$0.15
▼
$1.66
Volume
6.38 million shs
Average Volume
1.69 million shs
Market Capitalization
$25.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.33
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Recent Seelos Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
10/01/2023
11:15 PM		SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form EFFECT
10/02/2023
5:03 AM		SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2023
3:06 PM		SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2023
5:02 AM		SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 424B5
09/20/2023
6:00 AM		SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
8:00 AM		SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2023
3:15 PM		Golembiewski Michael Joseph (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
3:05 PM		SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/29/2023
8:00 AM		SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2023
5:01 AM		SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form DEFA14A
03/14/2023
3:32 PM		SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2023
6:01 AM		SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2023
8:01 PM		SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/09/2023
8:02 PM		SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/05/2023
6:20 PM		O'Connor Daniel J. (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2023
6:21 PM		Pascoe Richard W (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2023
6:18 PM		Lian Brian (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2023
6:19 PM		DALESANDRO MARGARET (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/23/2022
3:03 PM		SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/10/2022
3:06 PM		SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:SEEL) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -